SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001570562-18-000100
Filing Date
2018-08-02
Accepted
2018-08-02 16:10:33
Documents
49
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q evolus06301810-q.htm 10-Q 1168604
2 EXHIBIT 31.1 exhibit31106301810q.htm EX-31.1 14973
3 EXHIBIT 31.2 exhibit31206301810q.htm EX-31.2 15195
4 EXHIBIT 32.1 exhibit32106301810q.htm EX-32.1 11730
  Complete submission text file 0001570562-18-000100.txt   4381881

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT eols-20180630.xml EX-101.INS 642815
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eols-20180630.xsd EX-101.SCH 29195
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT eols-20180630_cal.xml EX-101.CAL 43579
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eols-20180630_def.xml EX-101.DEF 202969
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eols-20180630_lab.xml EX-101.LAB 416982
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eols-20180630_pre.xml EX-101.PRE 279371
Mailing Address 17901 VON KARMAN AVENUE, SUITE 150 IRVINE CA 92614
Business Address 17901 VON KARMAN AVENUE, SUITE 150 IRVINE CA 92614 (949) 284-4555
Evolus, Inc. (Filer) CIK: 0001570562 (see all company filings)

IRS No.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38381 | Film No.: 18988386
SIC: 2834 Pharmaceutical Preparations